Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperplasia × pegvisomant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Acromegaly 2 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Lung Neoplasms 1 Hyperplasia 1 Fibrous Dysplasia, Polyostotic 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenoma 1

Interventions

pegvisomant 1 Tirzepatide 1 Restraint, Physical 1 Microspheres 1 Metformin 1 Endoscopy 1 Eicosapentaenoic Acid 1 Colonoscopy 1 Clinical Chemistry Tests 1 Cholecalciferol 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00017927 2008-03-04

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

National Institutes of Health Clinical Center (CC)

Phase 3 Completed

Acromegaly, Adenoma, Fibrous Dysplasia, Polyostotic, Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡